Canaud B, Beraud J J, Joyeux H, Mion C
Artif Organs. 1986 Oct;10(5):397-403. doi: 10.1111/j.1525-1594.1986.tb02587.x.
Temporary and immediately usable vascular access is a vital need in treating uremic patients. Subclavian vein cannulation, although a major progress, has been associated with significant morbidity and mortality. Accordingly, for the last 2.5 years the authors have been developing an alternative technique consisting of internal jugular vein cannulation (IJVC) with two silicone rubber catheters with a long-term, proved biocompatibility. One hundred sixty-five pairs of cannulas were inserted in 153 patients. Mean duration of use was 57 days (1 day to 17 months). More than 3,000 high-performance hemodialysis sessions were performed. IJVC handling and care were easily managed by nurses. A low incidence of complications was observed: two thrombosis episodes, four skin infections with three septicemia, one air embolism, and one anaphylactoid reaction. No death was related to the technique itself. IJVC offers a new, safe, and reliable temporary vascular access immediately usable for all kinds of extracorporeal treatment.
对于尿毒症患者的治疗而言，临时且可立即使用的血管通路至关重要。锁骨下静脉插管虽取得了重大进展，但却伴随着较高的发病率和死亡率。因此，在过去的两年半时间里，作者一直在研发一种替代技术，即采用两根具有长期可靠生物相容性的硅橡胶导管进行颈内静脉插管（IJVC）。153例患者共插入了165对导管。平均使用时长为57天（1天至17个月）。进行了3000多次高效血液透析治疗。护士能够轻松管理IJVC的操作与护理。观察到并发症的发生率较低：2例血栓形成、4例皮肤感染伴3例败血症、1例空气栓塞和1例类过敏反应。未出现与该技术本身相关的死亡病例。IJVC为各类体外治疗提供了一种全新、安全且可靠的临时血管通路，可立即使用。
